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 OPEN ACCESS 
Dear Editor,
on March 11 2020, the World Health Organization 
(WHO) declared pandemic the disease caused by a novel 
coronavirus named SARS-CoV-2 (Severe Acute Respiratory 
Syndrome-CoronaVirus-2) that still now causes symptoms 
like fever, cough, sore throat, breathlessness, vomiting 
among others. The disease is mild in most people; in some 
patients (usually the elderly and those with comorbidities), 
it may progress to pneumonia, acute respiratory distress 
syndrome (ARDS) and multi organ dysfunction [1]. Many 
people are asymptomatic, but able to transmit the infection 
to others  [2]. Mortality estimated rate is about 5.6% [3]. 
Coronaviruses are enveloped, positive single-stranded large 
RNA viruses that infect humans, but also a wide range of 
animals. SARS-CoV-2 apparently succeeded in making its 
transition from animals to humans on the Huanan seafood 
market in Wuhan, China [4]. 
For the previous reasons, it is extremely important to 
individuate SARS-CoV-2 reservoirs: real-time fluorescence 
quantitative reverse transcriptase polymerase chain 
reaction (reverse transcriptase-polymerase chain reaction, 
RT-PCR) is the gold standard method in order to detect the 
infection [5]. A study suggests that the favorite biological 
sample should be sputum and nasopharyngeal swabs that 
minimize as much as possible the risk of false negative 
results (respective sensibility of 48.68 and 38.13%)  [5]. 
Other authors propose oropharyngeal swab as a procedure 
less sensible then nasopharyngeal [6].
In Italy, we normally run both nasopharyngeal and 
oropharyngeal swabs in every patient who suffers from 
symptoms suspicious for COVID-19 [7]. In our country, 
serological tests are not diffusely available and nobody 
demonstrated that the presence antibodies against SARS-
CoV-2 can protect from a reinfection [8, 9]. So patients, 
who are hospitalized or quarantined because of SARS-
CoV-2 infection, in order to interrupt the confinement, 
have to obtain two consecutive negative results for virus 
research in oropharyngeal and nasopharyngeal swabs, 
using RT-PCR [7]. 
Here we report the peculiar history of a patient, now still 
hospitalized in Celio Hub Covid-Hospital, in Rome, Italy. 
The requirement of informed consent was waived since 
patient information was anonymized to ensure privacy.
A 30-year-old woman, no smoker, with no comorbidities, 
no allergies and no previous hospitalization, started feeling 
fever (37.5°C), cough, and shortness of breath, anosmia and 
ageusia on 23rd March 2020. She was not taking any drugs, 
except for birth control pill. She is a medical doctor and 
she worked in February and March 2020 in some nursing 
home care near Milan, in the north of Italy. On 27th March 
she underwent oropharyngeal and nasopharyngeal swabs: 
the test result was positive, so she started the quarantine 
period at home alone. Then, her boyfriend, that lived with 
her, had smart-worked since 10th March 2020 and had not 
developed symptoms, immediately left their house and 
started living without any contact in his own apartment, but 
he has never undergone a PCR test. 
Without using any therapy, the young woman recovered in 
one week without any social interaction and she underwent 
new swabs on 14th and 15th April with negative results. All 
the three swabs were carried out in Milan by the same nurse. 
On 16th April she met again her boyfriend. Since she had to 
work in Rome, the couple travelled to the Italian capital and 
there she felt symptoms again: in particular, temperature 
(37.7°C) and fatigue. No cough, sore throat, or vomiting 
were reported.
On 17th April she and her boyfriend underwent 
oropharyngeal and nasopharyngeal swabs: all of them were 
positive and they were precautionarily hospitalized.
On admission, physical examination of the young woman 
revealed normal vital signs with oxygen saturation of 
99% breathing ambient air. Lung auscultation revealed no 
rhonchi. Blood routine tests, liver function, renal function, 
electrolytes were normal. Serological tests for SARS-
CoV-2 were not run [9]. Now she is still in the hospital and 
she is taking only enoxaparin 4,000 IU/die.
Since RT-PCR test serves as the gold standard method 
to confirm the infection of SARS-CoV-2 and leads the 
decision of patients’ discharging or quarantine interruption, 
false-negative results could hinder the prevention and 
control of the epidemic. 
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Some studies found a potentially high false negative rate of 
RT-PCR testing for SARS-CoV-2 in hospitalized patients 
with COVID-1  [5,  7]. In our case, the result of the two 
consecutive negative swabs should be trusted even because 
the personnel and the laboratory were the same of the first 
positive result. Nevertheless, the RT-PCR results showed 
a fluctuating trend  [10], but nobody demonstrated that 
recurrence of RT-PCR positivity for the novel coronavirus 
is not associated with new risk of being a virus spreader 
again, even if asymptomatic. Additionally, nobody 
demonstrated that all the recovered patients cannot get the 
symptomatic (or poorly symptomatic) infection again, even 
with a shorter incubation time. In our situation, we cannot 
rule out that our patient has been infected by her boyfriend 
who previously got the virus from her, in a ping-pong effect.
The recurrence rate in recovered  –  suggested by two 
consecutive negative swabs and absence of clinical 
symptoms [7] – patients after the hospital discharging or the 
end of quarantine is unknown and should be investigated. 
Further studies are needed in order to understand deeper 
the clinical and the epidemiological features of the virus. 
Several countries in the world, after a necessary period of 
lock down, are starting again their working activities and 
the infective risk will increase again in the next weeks. 
Since we are not able to rule out the risk of reinfection in 
patients clinically recovered and the possibility that they 
can spread the virus again, we should treat every citizen as 
infected and contagious, even if clinically recovered, until 
proven otherwise. In conclusion, we must be prepared to a 
future in which social distancing, face masks and virtuous 
sanitization procedures will be mandatory.
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